Novartis’s Afinitor helps Pfizer’s Aromasin to Delay Breast Cancer | The Haystack
Links shared publicly online about this topic.
- 0total visits
Novartis’s Afinitor helps Pfizer’s Aromasin to Delay Breast Cancer | The Haystack
Looks like Afinitor (everolimus), a drug marketed by Novartis for various cancers, may soon have a new indication. Already approved for a variety of diseases – kidney cancer, pancreatic tumors, and organ rejection prevention – Afinitor shows new promise for breast cancer patients. Clinical data released Monday demonstrate marked improvement for hormone-resistant breast cancer patients [...]
View full resource at cenblog.org
Tags: Cancer, Breast Cancer, Kidney Cancer Medication, Drug, Women's Health, Afinitor, Pfizer
Most Recently Shared on September 28, 2011 at 2:23 pm By:
When Afinitor, an mTOR inhibitor, is used in combination with the aromatase inhibitor Aromasin, good things happen http://t.co/CPulkAU5
Advertisement
